AXSM - axsome.com Uzoq muddatli majburiyatlarning kapitalga nisbati
Axsome Therapeutics (AXSM) sezilarli narx belgilash imkoniyatiga ega, chunki depressiyaning og'ir shakllaridagi bemorlar samarali terapiyadan kamdan-kam hollarda voz kechishadi. Joriy ko'rsatkich 1.74 darajasida turibdi, quyida tasvirlangan aksiya narxi esa tushumlar o'sishi ma'lumotlarini to'ldiradi, bu ma'lumotlar patent himoyasi tufayli makroiqtisodiy omillardan mustaqil qolmoqda. Axsome Therapeutics (AXSM) shuningdek, ilmiy tadqiqotlarga tayanib, migren va Altsgeymer kasalligi uchun davolash vositalarini ishlab chiqishga investitsiyalar kiritmoqda.
%3A%20Uzoq%20muddatli%20qarzning%20o'z%20kapitaliga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_AXSM_-_Axsome-Therapeutics_-_Long-Term-Debt-to-Equity-Ratio "AXSM: Axsome Therapeutics, Inc. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 28.10.2026 | 👁️GURU.Markets👁️")
Axsome Therapeutics (AXSM) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Kompaniyaning fundamental tahlili:Axsome
Axsome Therapeutics (AXSM) investori uchun tadqiqot va ishlanmalar (R&D) kapital intensivligi va moliyaviy barqarorlik o'rtasidagi muvozanat hal qiluvchi ahamiyatga ega. Ushbu uzoq muddatli qarzning sof aktivlarga nisbati kompaniyaning muddati bir yildan ortiq bo'lgan qarz mablag'lariga bog'liqligini o'lchaydi va bu haddan tashqari yuqori kredit yuklamasi (leverage) xavfini baholash imkonini beradi. Ushbu grafikda ko'rsatilgan past yuklama zavodlarga kapital xarajatlarsiz, shartnomaviy ishlab chiqarishdan foydalanadigan kengayish modelining samaradorligini tasdiqlaydi.
Toʻgʻridan-toʻgʻri raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi Biogen Inc|Neurocrine Biosciences Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Regencell Corp RGC|Uzoq muddatli qarzning o'z kapitaliga nisbati ACAD (ACADIA Pharmaceuticals)|xenon-pharma.com - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Viking Therapeutics, Inc. (VKTX)|SUPN: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati CPRX|Denali Corp (DNLI) - Uzoq muddatli majburiyatlarning kapitalga nisbati|HRMY (Harmony Biosciences) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati biohavenpharma.com (BHVN)|Uzoq muddatli qarzning o'z kapitaliga nisbati Amylyx Pharmaceuticals, Inc. AMLX|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TRVI (Trevi Therapeutics Inc)|Uzoq muddatli qarzning o'z kapitaliga nisbati PRAX|Anavex Life Sciences Corp - Uzoq muddatli qarzdorlikning kapitalga nisbati|CBLL (CeriBell, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PRTA: Uzoq muddatli majburiyatlarning kapitalga nisbati|ALEC (alector.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Annexon Biosciences (ANNX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati OMER (Omeros Corp)|Uzoq muddatli majburiyatlarning kapitalga nisbati Neurogene Therapeutics (NGNE)|AC Immune (ACIU) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti voyagertherapeutics.com VYGR|Uzoq muddatli qarzning o'z kapitaliga nisbati Neumora Therapeutics, Inc. (NMRA)|Uzoq muddatli kreditlarning kapitalga nisbati Scilex Holding SCLX|Uzoq muddatli qarzning kapitalga nisbati Tevogen Bio Holdings, Inc. (TVGN)|ACOG - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati CGTX|IKT (inhibikase.com) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SAVA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti Assertio Therapeutics|Uzoq muddatli qarzning kapitalga nisbati COYA|Uzoq muddatli qarzning kapitalga nisbati VTGN (vistagen.com)|Ovid Therapeutics (OVID) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati acumenpharm.com ABOS|CRVO (CervoMed) - Uzoq muddatli qarzning kapitalga nisbati|Alterity Therapeutics (ATHE) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CLNN: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati PepGen|Jupiter Neurosciences Inc (JUNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati relmada.com|ANVS (Annovis Bio) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati gracetx.com (GRCE)|Firefly Neuroscience Inc - Uzoq muddatli qarzning kapitalga nisbati|ANEW Medical - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NRSN (NeuroSense Therapeutics, Ltd.)|RVPH - Uzoq muddatli qarzdorlikning kapitalga nisbati|MTVA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati NeurAxis Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc. (HSDT)|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi PASG|NEUP (Neuphoria Therapeutics Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati NERV (minervaneurosciences.com)|Athira Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Addex Therapeutics Ltd. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Alzamend (ALZN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CYCN - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati PTIX|Uzoq muddatli majburiyatlarning kapitalga nisbati Pasithea Therapeutics Corp.|CRGT (Cortigent Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ATXI|Brainstorm Cell Therapeutics, Inc. (BCLI) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CARA (Cara Therapeutics Inc)|CHRO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Eliem Therapeutics, Inc. ELYM|Intra-Cellular - Uzoq muddatli qarzning kapitalga nisbati|Longboard Pharmaceuticals Inc (LBPH) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Marinus|NKGN (NKGen Biotech Corp) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|NRBO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati SAGE|Synaptogenix - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Anew Medical Inc. WENA|CERE (Cerevel Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati